Key facts
- Super Teeth’s last known valuation is $10.0M (Feb 2026).
- It has raised $3.0M; the latest was Seed Round ($3.0M) in Feb 2026.
- Notable investors include Cutting Horse.
- Status: Privately Held (backing).
Leadership
- Cameron DahlChief Executive Officer & Founder
- Katherine DahlChief Executive Officer & Chief Marketing Officer
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Super Teeth
- ·The full record, as it builds
Funding rounds
No funding rounds for Super Teeth are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Super Teeth
Manufacturer of probiotic oral care products designed for supporting teeth and gum health. The company's platform develops microbiome-based formulations for adults and children focused on preventive care, enabling health-conscious consumers to support oral wellness through daily use.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Boston, MA, United States
- Founded
- 2021
- Employees
- 5
- Website
- getsuperteeth.com/
- Ownership
- Privately Held (backing)
Super Teeth doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Super Teeth shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Super Teeth in its N-PORT filings yet. We sweep new filings monthly.